Population pharmacokinetics and dose optimization of levofloxacin in elderly patients with pneumonia
British Journal of Clinical Pharmacology · 2024
DOI: 10.1111/bcp.16003 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, 2024. Verfasst von Yun-Ying He und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Institute of Clinical Pharmacology, Key Laboratory of Chemical Biology (Ministry of Education), NMPA Key Laboratory …. Hauptthemen laut MEDLINE: Levofloxacin, Monte Carlo Method, Anti-Bacterial Agents, Models, Biological. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: National Key R&D Program of China, Distinguished Expert of Taishan Scholars Shandong Province Project, Innovation and Development Joint Fund of Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Aims
Levofloxacin is a quinolone antibiotic with a broad antibacterial spectrum. It is frequently used in elderly patients with pneumonia. The pharmacokinetic profile of elderly patients changes with age, but data on the pharmacokinetics of levofloxacin in these patients are limited. The aim of this study was to establish a population pharmacokinetic model of levofloxacin in elderly patients with pneumonia and to optimize individualized dosing regimens based on this newly developed model.
Methods
This is a prospective, open‐label pharmacokinetic study in elderly patients with pneumonia. Blood samples were collected using an opportunistic approach. The plasma concentrations of levofloxacin were determined by high‐performance liquid chromatography. A population pharmacokinetic model was established using nonlinear mixed‐effect model software. Monte Carlo simulations were used for dose simulation and dose optimization.
Results
Data from 51 elderly patients with pneumonia were used for the population pharmacokinetic analysis. A one‐compartment model with first‐order elimination was most suitable for describing the data, and the estimated glomerular filtration rate was the only covariate that had a significant impact on the model. The final model estimated that the mean clearance of levofloxacin in elderly patients with pneumonia was 5.26 L/h. Monte Carlo simulation results showed that the optimal dosing regimen for levofloxacin was 750 mg once a day in elderly patients with pneumonia, with a minimum inhibitory concentration of 2 mg/L.
Conclusions
The population pharmacokinetic model of levofloxacin in elderly patients with pneumonia was established, and the dose optimization of levofloxacin was completed through Monte Carlo simulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacy, Institute of Clinical Pharmacology, Key Laboratory of Chemical Biology (Ministry of Education), NMPA Key Laboratory for Clinical Research and Evaluation of Innovative Drug, School of Pha…
- Department of Pharmacy, The Second Hospital of Shandong University, Jinan, China.
- Department of Respiratory, The Second Hospital of Shandong University, Jinan, China.
- Division of Clinical Pharmacology, Children's National Hospital, Washington, District of Columbia, USA.
- Departments of Pediatrics, Pharmacology & Physiology, Genomics and Precision Medicine, School of Medicine and Health Sciences, George Washington University, Washington, District of Columbia, USA.
- Department of Paediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel, University of Basel, Basel, Switzerland.
ORCID-Profile: Wei Zhao
Förderung
- National Key R&D Program of China
- Distinguished Expert of Taishan Scholars Shandong Province Project
- Innovation and Development Joint Fund of Natural Science Foundation of Shandong Province
- National Key Research and Development Program of China
Zitieren
APA
He, Y. Y., Sun, J., Wu, Y. E., Wang, Y. B., van den Anker, J., Hao, G. X., Sun, D. Q., & Zhao, W. (2024). Population pharmacokinetics and dose optimization of levofloxacin in elderly patients with pneumonia. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.16003
Vancouver
He YY, Sun J, Wu YE, Wang YB, van den Anker J, Hao GX, et al. Population pharmacokinetics and dose optimization of levofloxacin in elderly patients with pneumonia. British Journal of Clinical Pharmacology. 2024. doi:10.1111/bcp.16003
BibTeX
@article{He2024,
author = {He, Yun-Ying and Sun, Jing and Wu, Yue-E and Wang, Yong-Bin and van den Anker, John and Hao, Guo-Xiang and Sun, De-Qing and Zhao, Wei},
title = {Population pharmacokinetics and dose optimization of levofloxacin in elderly patients with pneumonia},
journal = {British Journal of Clinical Pharmacology},
year = {2024},
doi = {10.1111/bcp.16003}
}
EUVIMED